Pushpakumar Sathnur, Kundu Sourav, Pryor Tyranny, Givvimani Srikanth, Lederer Eleanor, Tyagi Suresh C, Sen Utpal
aDepartment of Physiology and Biophysics bRobley Rex VA Medical Center cDivision of Nephrology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
J Hypertens. 2013 Nov;31(11):2270-81; discussion 2281. doi: 10.1097/HJH.0b013e3283649b33.
Sustained hypertension induces renovascular remodelling by altering extracellular matrix (ECM) components. Matrix metalloproteinases (MMPs) are Zn-dependent enzymes that regulate ECM turnover in concert with their inhibitors, tissue inhibitors of metalloproteinases (TIMPs). Increased MMP-2 and MMP-9 have been implicated in hypertensive complications; however, the contribution of individual MMPs/TIMPs in renal remodelling has not been fully elucidated. The purpose of this study was to determine the effect of TIMP2 deficiency and thus MMP-2 on angiotensin-II (Ang-II) induced renal remodelling.
C57BL/6J (wild-type) and TIMP2 knockout mice were infused with Ang-II at 250 ng/kg per min for 4 weeks. Blood pressure was measured weekly and end-point laser Doppler flowmetry was done to assess cortical blood flow. Immunohistochemical staining was performed for collagen and elastin analyses. The activity of MMP-9 and MMP-2 was determined by Gelatin zymography.
Ang-II induced similar elevation in mean blood pressure in TIMP2 and wild-type mice. In TIMP2 mice, Ang-II treatment was associated with a greater reduction in renal cortical blood flow and barium angiography demonstrated decreased vascular density compared with Ang-II treated wild-type mice. Peri-glomerular and vascular collagen deposition was increased and elastin content was decreased causing increased wall-to-lumen ratio in TIMP2 mice compared with wild-type mice receiving Ang-II. Ang-II increased the expression and activity of MMP-9 predominantly in TIMP2 mice than in wild-type mice.
These results suggest that TIMP2 deficiency exacerbates renovascular remodelling in agonist-induced hypertension by a mechanism that may, in part, be attributed to increased activity of MMP-9.
持续性高血压通过改变细胞外基质(ECM)成分诱导肾血管重塑。基质金属蛋白酶(MMPs)是锌依赖性酶,与它们的抑制剂金属蛋白酶组织抑制剂(TIMPs)协同调节ECM周转。MMP-2和MMP-9的增加与高血压并发症有关;然而,个体MMPs/TIMPs在肾脏重塑中的作用尚未完全阐明。本研究的目的是确定TIMP2缺乏以及由此导致的MMP-2对血管紧张素II(Ang-II)诱导的肾脏重塑的影响。
将C57BL/6J(野生型)和TIMP2基因敲除小鼠以每分钟250 ng/kg的剂量输注Ang-II,持续4周。每周测量血压,并进行终点激光多普勒血流仪检测以评估皮质血流。进行免疫组织化学染色以分析胶原蛋白和弹性蛋白。通过明胶酶谱法测定MMP-9和MMP-2的活性。
Ang-II在TIMP2和野生型小鼠中诱导了相似的平均血压升高。在TIMP2小鼠中,与接受Ang-II治疗的野生型小鼠相比,Ang-II治疗导致肾皮质血流的更大减少,钡剂血管造影显示血管密度降低。与接受Ang-II的野生型小鼠相比,TIMP2小鼠的肾小球周围和血管胶原蛋白沉积增加,弹性蛋白含量降低,导致壁腔比增加。与野生型小鼠相比,Ang-II主要在TIMP2小鼠中增加了MMP-9的表达和活性。
这些结果表明,TIMP2缺乏通过一种可能部分归因于MMP-9活性增加的机制加剧了激动剂诱导的高血压中的肾血管重塑。